Search results for "Phylogenetics"

showing 10 items of 777 documents

Oral postinflammatory pigmentation : an analysis of 7 cases

2010

Oral postinflammatory pigmentation (OPP) is a discoloration of the oral mucosa caused by an excess of melanin production and deposition within the basal layer of the epithelium and connective tissue of areas affected by chronic inflammation. Therefore, it is mandatory to demonstrate the association with a previous or concomitant inflammatory process in the same area of oral mucosa. Clinically OPP appears as a localized or diffuse, black to brown pigmentation. OPP may persist for many years even though the disappearing of the pigmentation after the resolution of the inflammatory state has been reported. We reviewed retrospectively the medical records and, when performed, biopsy examinations …

AdultMalePathologymedicine.medical_specialtyConnective tissueMelaninBasal (phylogenetics)BiopsymedicineHumansOral mucosaGeneral DentistryAgedRetrospective StudiesHypopigmentationStomatitisHigh prevalencemedicine.diagnostic_testbusiness.industryMouth MucosaMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]stomatognathic diseasesmedicine.anatomical_structureOtorhinolaryngologyConcomitantUNESCO::CIENCIAS MÉDICASFemaleSurgeryOral lichen planusbusiness
researchProduct

Differential metallothionein expression in oral lichen planus and amalgam-associated oral lichenoid lesions

2017

Background Oral lichen planus (OLP) is a chronic inflammatory disease mediated by T cells, which manifests as reticular (white) or erosive (red) lesions, that are eventually painful. Oral lichenoid lesion (OLL) are distinguished from OLP by the presence of precipitating factors. The aim of this study was to evaluate whether the presence of metallothionein, which is involved in anti-apoptotic pathways and the anti-oxidative response, could serve as a differential diagnostic for OLP and OLL. Material and Methods We evaluated the expression of metallothionein in 40 cases of OLP and 20 cases of OLL using immunohistochemistry. Results and Conclusions White OLP has higher concentrations of metall…

AdultMalePathologymedicine.medical_specialtyDental AmalgamDiagnosis DifferentialLesion03 medical and health sciencesBasal (phylogenetics)0302 clinical medicinestomatognathic systemHumansMedicineMetallothioneinGeneral DentistryLichenoid lesionsOral Medicine and Pathologybusiness.industryResearch030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASReticular connective tissueImmunohistochemistryFemaleMetallothioneinSurgeryOral lichen planusDifferential diagnosismedicine.symptomMouth DiseasesbusinessLichen Planus OralMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Differential expression of Cyclin D1 in keratin-producing odontogenic cysts

2015

Objetives: The aim of the present study was to analyze the expression levels of Cyclin D1 (CCD1), a nuclear protein that plays a crucial role in cell cycle progression, in a series of keratin-producing odontogenic cysts. Study Design: A total of 58 keratin-producing odontogenic cysts, diagnosed over ten years and classified according to the WHO 2005 criteria, were immunohistochemically analyzed in terms of CCD1 expression, which was quantified in the basal, suprabasal and intermediate/superficial epithelial compartments. The extent of immunostaining was measured as a proportion of total epithelial thickness. Quantified immunohistochemical data were correlated with clinicopathological featur…

AdultMalePathologymedicine.medical_specialtycyclin D1keratocystNevoid basal-cell carcinoma syndromeOdontologíaBiologyorthokeratinized odontogenic cystBasal (phylogenetics)Cyclin D1Odontogenic cystnevoid basal cell carcinoma syndromemedicineHumansCyclin D1KeratocystGeneral DentistryRetrospective StudiesOral Medicine and PathologyResearchKeratin-producing odontogenic cystkeratocystic odontogenic tumorMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludOtorhinolaryngologyimmunohistochemistryUNESCO::CIENCIAS MÉDICASOdontogenic CystsImmunohistochemistryKeratinsSurgeryKeratocystic Odontogenic TumorFemalemedicine.symptomImmunostainingJaw DiseasesMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

A replication study on P300 single trial analysis in schizophrenia: confirmation of a reduced number of 'true positive' P300 waves.

2000

A single trial analysis of event-related potentials (auditory odd-ball paradigm) of 20 schizophrenics was performed in comparison to matched healthy controls. The purpose of the study was to test the hypothesis that in schizophrenia the well-known P300 amplitude reduction of averaged event-related potentials is due to fewer elicited single trial P300 waves. The results of the present study support this finding of our previous exploratory investigation and point to the view that schizophrenics reveal basal disturbances in information processing due to inadequately elicited electrophysiological responses to target stimuli.

AdultMalePsychosisBasal (phylogenetics)Replication (statistics)medicineHumansFalse Positive ReactionsBiological PsychiatryBrainCognitionMiddle Agedmedicine.diseaseP300 amplitudeEvent-Related Potentials P300Psychiatry and Mental healthElectrophysiologySchizophreniaCase-Control StudiesAuditory PerceptionEvoked Potentials AuditorySchizophreniaFemaleSingle trialPsychologyNeuroscienceJournal of psychiatric research
researchProduct

Effectiveness of opioid rotation in the control of cancer pain: The ROTODOL Study

2014

Objective: To assess the effectiveness of opioid rotation (OR) to manage cancer pain. To describe the adverse events (AEs) associated with OR. Setting: Thirty-nine tertiary hospital services.Patients: Sixty-seven oncological patients with cancer-related pain treated at outpatient clinics.Intervention: Prospective multicenter study. Pain intensity was scored using a Numerical Rating Scale (NRS) of 0-10. Average pain (AP) intensity in the last 24 hours, breakthrough pain (BTP), and the number of episodes of BTP on the days before and 1 week after OR were assessed. The pre-OR and post-OR opioid were recorded. The presence and intensity of any AEs occurring after OR were also recorded.Results: …

AdultMaleTime FactorsSeverity of Illness IndexDrug Administration ScheduleTertiary Care CentersBasal (phylogenetics)AnalgèsicsRating scaleOpioid rotationNeoplasmsHumansMedicineOutpatient clinicPharmacology (medical)Prospective StudiesAdverse effectAgedPain MeasurementAged 80 and overDrug Substitutionbusiness.industryBreakthrough PainGeneral MedicineMiddle AgedIntensity (physics)Analgesics OpioidTreatment OutcomeAnesthesiology and Pain MedicineOpioidSpainAnesthesiaFemaleChronic PainOpiDolor oncològicbusinessCancer painmedicine.drugJournal of Opioid Management
researchProduct

Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan

2007

Objective: We designed this trial to investigate if modifications in levels of circulating vascular endothelial growth factor (VEGF) may be related to clinical response and outcome in advanced colorectal cancer patients during treatment with a weekly combination of cetuximab plus irinotecan. Methods: A total of 45 heavily pretreated metastatic colorectal cancer patients were prospectively evaluated for circulating levels of VEGF during the treatment with cetuximab plus weekly irinotecan. VEGF circulating levels were assessed at the following time points: just before and at 1, 21, 50 and 92 days after the start of cetuximab plus irinotecan treatment. Results: Basal VEGF median levels were s…

AdultMaleVascular Endothelial Growth Factor AOncologymedicine.medical_specialtyAngiogenesisColorectal cancerCetuximabAntibodies Monoclonal HumanizedIrinotecanangiogenesiscetuximabcolorectal canceririnotecansurvivalvascular endothelial growth factorBasal (phylogenetics)chemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorGeneticsmedicineHumansProspective StudiesProspective cohort studyAgedPharmacologyCetuximabbusiness.industryAntibodies MonoclonalMiddle Agedmedicine.diseaseSurvival RateClinical trialVascular endothelial growth factorIrinotecanTreatment OutcomechemistryDisease ProgressionMolecular MedicineCamptothecinFemaleColorectal Neoplasmsbusinessmedicine.drugPharmacogenomics
researchProduct

Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients

2006

INTRODUCTION Angiogenesis has been correlated with increased invasion and metastases in a variety of human neoplasms. Inadequate inhibition of the growth of tumor microvessels by anticancer agents may result in treatment failure, rated clinically as progressive or stable disease. We designed this trial to investigate the modification of the vascular endothelial growth factor (VEGF) and interferon-gamma (IFN-gamma) in advanced colorectal cancer patients during treatment with a weekly combination of cetuximab plus irinotecan. MATERIALS AND METHODS Forty-five metastatic colorectal cancer patients were prospectively evaluated for circulating levels of VEGF and IFN-gamma during the treatment wit…

AdultMaleVascular Endothelial Growth Factor Amedicine.medical_specialtyAngiogenesisColorectal cancerCetuximabAntibodies Monoclonal HumanizedIrinotecanGastroenterologyNeovascularizationInterferon-gammaBasal (phylogenetics)chemistry.chemical_compoundangiogenesis cetuximab colorectal cancer irinotecanInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansProspective StudiesProspective cohort studyAgedNeovascularization PathologicCetuximabbusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseVascular endothelial growth factorIrinotecanTreatment OutcomeEndocrinologyOncologychemistryCamptothecinFemalemedicine.symptomColorectal Neoplasmsbusinessmedicine.drug
researchProduct

Thyroid function and release of thyroid-stimulating hormone and prolactin from the pituitary in human obesity

1991

Thyroid function, basal serum thyroid-stimulating hormone (TSH) and prolactin concentrations, and the effects of 200 micrograms TSH-releasing hormone (TRH) given intravenously on TSH (delta TSH) and prolactin (delta prolactin) were investigated in 25 euthyroid obese subjects and 20 lean controls. No significant differences in serum thyroid hormone concentrations, glucose metabolism parameters, or basal TSH and prolactin concentrations were detected between groups, but a significant (P less than 0.01) increase in delta TSH and a significant (P less than 0.01) decrease in delta prolactin were observed in obese subjects. No significant differences in basal TSH and prolactin were observed in ob…

AdultMaleendocrine system030213 general clinical medicinemedicine.medical_specialtyTime Factorsendocrine system diseasesThyroid GlandThyrotropin030209 endocrinology & metabolismPeptide hormoneBiochemistry03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineSex FactorsThyroid-stimulating hormoneInternal medicinemedicineHumansEuthyroidObesityThyrotropin-Releasing Hormonebusiness.industryBiochemistry (medical)ThyroidCell BiologyGeneral MedicineProlactinProlactinmedicine.anatomical_structureEndocrinologyPituitary GlandFemaleThyroid functionbusinesshormones hormone substitutes and hormone antagonistsHormone
researchProduct

2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papil…

2004

Objective: Determination of early prognostic factors in patients with recurrent respiratory papillomatosis is extremely important, so the major goal of our prospective, multicentre study was to evaluate (1) the feasibility of various factors to determine prognosis of the clinical course,as well as (2) the response to interferon-alpha therapy in recurrent respiratory papillomatosis. Methods: Forty-two patients with recurrent respiratory papillomatosis were treated with interferon-alpha (3 MU/m2 three times per week; mean therapy duration was 2.7 ± 1.8 years)in 1983–1994 and followed-up until 2003. Human papilloma virus (HPV) type, recurrent respiratory papillomatosis severity and 2′,5′-oligo…

AdultMalemedicine.medical_specialtyAdolescent2'-5'-oligoadenylate synthetase activityAntineoplastic AgentsGastroenterologySeverity of Illness IndexVirusMalignant transformationBasal (phylogenetics)Internal medicinemedicine2'5'-Oligoadenylate SynthetaseHumansTypingProspective StudiesChildPapillomaviridaePapillomabusiness.industryInterferon-alphaGeneral Medicinemedicine.diseasePrognosisRespiratory Tract NeoplasmsTreatment OutcomeOtorhinolaryngologyChild PreschoolImmunologyDNA ViralLeukocytes MononuclearPapillomaFemaleRecurrent Respiratory PapillomatosisNeoplasm Recurrence LocalAirwaybusinessThe Journal of laryngology and otology
researchProduct

Serum hormones in soldiers after basic training: effect of added strength or endurance regimens.

2009

Introduction Military personnel are often exposed to training programs and operational situations that involve multiple stressors such as caloric deficit, sleep deprivation, and prolonged physical effort, which may disturb body homeostasis, as indicated by hormonal responses.Therefore, we investigated the effects of three training regimens on serum basal hormone concentrations before and after the 8-wk basic training (BT) period, and whether possible changes in serum basal concentrations are related to changes in endurance and strength performance. Methods Serum hormone levels were measured in 3 groups of 24 male military conscripts before and after 3 different types of training programs: n…

AdultMalemedicine.medical_specialtyAdolescentStrength trainingPhysical fitnessBasal (phylogenetics)Young AdultOxygen ConsumptionEndurance trainingInternal medicineMedicineHumansTestosteroneMuscle StrengthMilitary MedicineAerobic capacityTestosteroneExercise Tolerancebusiness.industryPublic Health Environmental and Occupational HealthTraining effectCortisoneThyroxineEndocrinologyMilitary PersonnelPhysical FitnessBody CompositionbusinessHormoneAviation, space, and environmental medicine
researchProduct